APA aipamena

Booth, L., Roberts, J. L., Sander, C., Lee, J., Kirkwood, J. M., Poklepovic, A., & Dent, P. (2017). The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget.

Chicago Style aipamena

Booth, Laurence, Jane L. Roberts, Cindy Sander, John Lee, John M. Kirkwood, Andrew Poklepovic, and Paul Dent. "The HDAC Inhibitor AR42 Interacts With Pazopanib to Kill Trametinib/dabrafenib-resistant Melanoma Cells in Vitro and in Vivo." Oncotarget 2017.

MLA aipamena

Booth, Laurence, et al. "The HDAC Inhibitor AR42 Interacts With Pazopanib to Kill Trametinib/dabrafenib-resistant Melanoma Cells in Vitro and in Vivo." Oncotarget 2017.